343 related articles for article (PubMed ID: 15352988)
21. Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.
Rodríguez-Luaces M; Ferrá C; Martín-Henao G; Berlanga JJ; Grañena A; Gallardo D
Eur J Haematol; 2004 Sep; 73(3):162-8. PubMed ID: 15287912
[TBL] [Abstract][Full Text] [Related]
22. Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Saito AM; Kami M; Mori S; Kanda Y; Suzuki R; Mineishi S; Takami A; Taniguchi S; Takemoto Y; Hara M; Yamaguchi M; Hino M; Yoshida T; Kim SW; Hori A; Ohashi Y; Takaue Y
Am J Hematol; 2007 Oct; 82(10):873-80. PubMed ID: 17570513
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C
Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578
[TBL] [Abstract][Full Text] [Related]
24. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Baron F; Schaaf-Lafontaine N; Humblet-Baron S; Meuris N; Castermans E; Baudoux E; Frère P; Bours V; Fillet G; Beguin Y
Transplantation; 2003 Dec; 76(12):1705-13. PubMed ID: 14688520
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.
Maury S; Lemoine FM; Hicheri Y; Rosenzwajg M; Badoual C; Cheraï M; Beaumont JL; Azar N; Dhedin N; Sirvent A; Buzyn A; Rubio MT; Vigouroux S; Montagne O; Bories D; Roudot-Thoraval F; Vernant JP; Cordonnier C; Klatzmann D; Cohen JL
Sci Transl Med; 2010 Jul; 2(41):41ra52. PubMed ID: 20650872
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect.
Díez-Martín JL; Gómez-Pineda A; Serrano D; Carrión R; Balsalobre P; Buño I
Bone Marrow Transplant; 2004 May; 33(10):1037-41. PubMed ID: 15064692
[TBL] [Abstract][Full Text] [Related]
27. Current status of haploidentical stem cell transplantation.
Dey BR; Spitzer TR
Br J Haematol; 2006 Nov; 135(4):423-37. PubMed ID: 16984391
[TBL] [Abstract][Full Text] [Related]
28. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
[TBL] [Abstract][Full Text] [Related]
29. Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC.
Baron F; Baudoux E; Frère P; Tourqui S; Schaaf-Lafontaine N; Herens C; DePrijck B; Fillet G; Beguin Y
Bone Marrow Transplant; 2003 Oct; 32(8):829-34. PubMed ID: 14520430
[TBL] [Abstract][Full Text] [Related]
30. Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis.
Elhasid R; Arush MB; Zaidman I; Leiba R; Barak AB; Postovsky S; Haddad N; Katz T; Pollack S; Sami I; Gidoni O; Rubin D; Mandel H; Attias D; Reisner Y; Etzioni A; Rowe JM
Biol Blood Marrow Transplant; 2007 Mar; 13(3):329-38. PubMed ID: 17317586
[TBL] [Abstract][Full Text] [Related]
31. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
Ho VT; Kim HT; Li S; Hochberg EP; Cutler C; Lee SJ; Fisher DC; Milford E; Kao G; Daley H; Levin J; Ng A; Mauch P; Alyea EP; Antin JH; Soiffer RJ
Bone Marrow Transplant; 2004 Dec; 34(11):987-94. PubMed ID: 15489873
[TBL] [Abstract][Full Text] [Related]
32. Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation.
Cottler-Fox M; Cipolone K; Yu M; Berenson R; O'Shaughnessy J; Dunbar C
Exp Hematol; 1995 Apr; 23(4):320-2. PubMed ID: 7534711
[TBL] [Abstract][Full Text] [Related]
33. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
34. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.
Bishop MR; Fowler DH; Marchigiani D; Castro K; Kasten-Sportes C; Steinberg SM; Gea-Banacloche JC; Dean R; Chow CK; Carter C; Read EJ; Leitman S; Gress R
J Clin Oncol; 2004 Oct; 22(19):3886-92. PubMed ID: 15314059
[TBL] [Abstract][Full Text] [Related]
37. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Baron F; Maris MB; Storer BE; Sandmaier BM; Panse JP; Chauncey TR; Sorror M; Little MT; Maloney DG; Storb R; Heimfeld S
Leukemia; 2005 May; 19(5):822-8. PubMed ID: 15772701
[TBL] [Abstract][Full Text] [Related]
38. Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.
Wiesmann A; Bader P; Bamberg M; Faul C; Kanz L; Einsele H
Bone Marrow Transplant; 2003 Sep; 32(5):511-3. PubMed ID: 12942098
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
40. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
